Corcept Therapeutics | CORT - 流动资产



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 11.92B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


流动资产 更改 日
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Alaunos Therapeutics USD 970K 1.02M 2026-03
ANI Pharmaceuticals USD 825.43M 78.35M 2026-06
Ardelyx USD 381.87M 447K 2026-03
Aurora Cannabis CAD 397.45M 48.38M 2026-03
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Canopy Growth CAD 529.47M 4.8M 2026-03
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
J&J USD 59.77B 601M 2026-06
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
Merck USD 36.68B 1.66B 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novartis USD 27.35B 744M 2026-06
Novartis USD 26.61B 3.85B 2026-03
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 615.21M 100.25M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
TG Therapeutics USD 1.15B 58.72M 2026-06